blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3556427

EP3556427 - TRANSVASCULAR NERVE STIMULATION APPARATUS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.04.2023
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  06.05.2022
FormerGrant of patent is intended
Status updated on  10.01.2022
FormerExamination is in progress
Status updated on  03.04.2021
FormerRequest for examination was made
Status updated on  29.05.2020
FormerThe application has been published
Status updated on  20.09.2019
Most recent event   Tooltip09.02.2024Lapse of the patent in a contracting state
New state(s): IT		published on 13.03.2024  [2024/11]
Applicant(s)For all designated states
Lungpacer Medical Inc.
8602 Commerce Court
Burnaby BC V5A 4N6 / CA
[2019/43]
Inventor(s)01 / HOFFER, Joaquin Andres
241 Strong Road
Anmore, British Columbia V3H 5E9 / CA
02 / NOLETTE, Marc-Andre
4428 Pandora Street
Burnaby, British Columbia V5C 2B9 / CA
03 / THAKKAR, Viral
219 Bayberry Drive
Chester Springs, Pennsylvania 19425 / US
04 / TRAN, Bao Dung
5886 Lanark Street
Vancouver, British Columbia V5P 2Y5 / CA
 [2020/20]
Former [2019/43]01 / HOFFER, Joaquin Andres
241 Strong Road
Anmore, British Columbia V3H 5E9 / CA
02 / NOLETTE, Marc-Andre
4428 Pandora Street
Burnaby, British Columbia V5C 2B9 / CA
03 / THAKKAR, Viral
3003 Carina Place
Burnaby, British Columbia V5A 1B4 / CA
04 / TRAN, Bao Dung
5886 Lanark Street
Vancouver, British Columbia V5P 2Y5 / CA
Representative(s)Isarpatent
Patent- und Rechtsanwälte Barth
Charles Hassa Peckmann & Partner mbB
Friedrichstrasse 31
80801 München / DE
[2022/23]
Former [2019/43]Isarpatent
Patent- und Rechtsanwälte Behnisch Barth Charles
Hassa Peckmann & Partner mbB
Friedrichstrasse 31
80801 München / DE
Application number, filing date19178080.804.03.2013
[2019/43]
Priority number, dateUS201261606899P05.03.2012         Original published format: US 201261606899 P
[2019/43]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP3556427
Date:23.10.2019
Language:EN
[2019/43]
Type: A3 Search report 
No.:EP3556427
Date:27.11.2019
Language:EN
[2019/48]
Type: B1 Patent specification 
No.:EP3556427
Date:08.06.2022
Language:EN
[2022/23]
Search report(s)(Supplementary) European search report - dispatched on:EP28.10.2019
ClassificationIPC:A61N1/05, A61N1/36
[2019/43]
CPC:
A61N1/0551 (EP,CN,US); A61N1/3601 (EP,CN,US); A61N1/3605 (CN)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/27]
Former [2019/43]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:TRANSVASKULÄRE NERVENSTIMULATIONSVORRICHTUNG[2019/43]
English:TRANSVASCULAR NERVE STIMULATION APPARATUS[2019/43]
French:APPAREIL DE STIMULATION NERVEUSE TRANSVASCULAIRE[2019/43]
Examination procedure27.05.2020Amendment by applicant (claims and/or description)
27.05.2020Examination requested  [2020/27]
27.05.2020Date on which the examining division has become responsible
21.10.2020Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time
06.04.2021Despatch of a communication from the examining division (Time limit: M04)
16.08.2021Reply to a communication from the examining division
11.01.2022Communication of intention to grant the patent
28.04.2022Fee for grant paid
28.04.2022Fee for publishing/printing paid
28.04.2022Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP13758363.9  / EP2822645
EP17169051.4  / EP3228351
Divisional application(s)EP22177112.4  / EP4070850
Opposition(s)10.03.2023No opposition filed within time limit [2023/20]
Fees paidRenewal fee
02.10.2019Renewal fee patent year 03
02.10.2019Renewal fee patent year 04
02.10.2019Renewal fee patent year 05
02.10.2019Renewal fee patent year 06
02.10.2019Renewal fee patent year 07
21.12.2020Renewal fee patent year 08
29.03.2021Renewal fee patent year 09
28.03.2022Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.03.202008   M06   Fee paid on   21.12.2020
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL08.06.2022
AT08.06.2022
CZ08.06.2022
DK08.06.2022
EE08.06.2022
ES08.06.2022
FI08.06.2022
HR08.06.2022
IT08.06.2022
LT08.06.2022
LV08.06.2022
MC08.06.2022
PL08.06.2022
RO08.06.2022
RS08.06.2022
SE08.06.2022
SI08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
GR09.09.2022
IS08.10.2022
PT10.10.2022
LU04.03.2023
[2024/11]
Former [2024/02]AL08.06.2022
AT08.06.2022
CZ08.06.2022
DK08.06.2022
EE08.06.2022
ES08.06.2022
FI08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
MC08.06.2022
PL08.06.2022
RO08.06.2022
RS08.06.2022
SE08.06.2022
SI08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
GR09.09.2022
IS08.10.2022
PT10.10.2022
LU04.03.2023
Former [2023/48]AL08.06.2022
AT08.06.2022
CZ08.06.2022
DK08.06.2022
EE08.06.2022
ES08.06.2022
FI08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
MC08.06.2022
PL08.06.2022
RO08.06.2022
RS08.06.2022
SE08.06.2022
SI08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
GR09.09.2022
IS08.10.2022
PT10.10.2022
Former [2023/25]AL08.06.2022
AT08.06.2022
CZ08.06.2022
DK08.06.2022
EE08.06.2022
ES08.06.2022
FI08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
PL08.06.2022
RO08.06.2022
RS08.06.2022
SE08.06.2022
SI08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
GR09.09.2022
IS08.10.2022
PT10.10.2022
Former [2023/21]AL08.06.2022
AT08.06.2022
CZ08.06.2022
DK08.06.2022
EE08.06.2022
ES08.06.2022
FI08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
PL08.06.2022
RO08.06.2022
RS08.06.2022
SE08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
GR09.09.2022
IS08.10.2022
PT10.10.2022
Former [2023/17]AL08.06.2022
AT08.06.2022
CZ08.06.2022
EE08.06.2022
ES08.06.2022
FI08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
PL08.06.2022
RO08.06.2022
RS08.06.2022
SE08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
GR09.09.2022
IS08.10.2022
PT10.10.2022
Former [2023/12]AT08.06.2022
CZ08.06.2022
EE08.06.2022
ES08.06.2022
FI08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
PL08.06.2022
RO08.06.2022
RS08.06.2022
SE08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
GR09.09.2022
IS08.10.2022
PT10.10.2022
Former [2023/11]AT08.06.2022
CZ08.06.2022
EE08.06.2022
ES08.06.2022
FI08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
PL08.06.2022
RO08.06.2022
RS08.06.2022
SE08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
GR09.09.2022
PT10.10.2022
Former [2023/09]AT08.06.2022
CZ08.06.2022
EE08.06.2022
ES08.06.2022
FI08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
RO08.06.2022
RS08.06.2022
SE08.06.2022
SK08.06.2022
SM08.06.2022
BG08.09.2022
NO08.09.2022
GR09.09.2022
PT10.10.2022
Former [2023/07]AT08.06.2022
ES08.06.2022
FI08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
RS08.06.2022
SE08.06.2022
BG08.09.2022
NO08.09.2022
GR09.09.2022
Former [2022/50]ES08.06.2022
FI08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
RS08.06.2022
SE08.06.2022
BG08.09.2022
NO08.09.2022
GR09.09.2022
Former [2022/49]ES08.06.2022
FI08.06.2022
HR08.06.2022
LT08.06.2022
LV08.06.2022
SE08.06.2022
BG08.09.2022
NO08.09.2022
GR09.09.2022
Former [2022/47]ES08.06.2022
FI08.06.2022
LT08.06.2022
SE08.06.2022
NO08.09.2022
Documents cited:Search[X]US2004111139  (MCCREERY DOUGLAS B [US]) [X] 1-8 * abstract *;
 [A]WO2008092246  (UNIV FRASER SIMON [CA], et al) [A] 1-8 * the whole document *;
 [A]US2011230945  (OHTAKA NAOKI [JP], et al) [A] 1-8 * abstract * * paragraphs [0138] , [ 410] * * paragraphs [0280] - [0399] ** paragraphs [0593] - [0594] *;
 [A]WO2011158410  (JAPAN LIFELINE CO LTD [JP], et al) [A] 1-8
ExaminationUS2012029509
by applicantUS2010036451
    - LEVINE et al., New England Journal of Medicine, (20080000), vol. 358, pages 1327 - 1335
 US20090524571
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.